Login / Signup

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis.

Marcus J DrakeVictor W NittiDavid A GinsbergBenjamin M BruckerZsolt HeppRachael McCoolJulie M GlanvilleKelly J FleetwoodDaniel JamesChristopher R Chapple
Published in: BJU international (2017)
The results indicate that, after 12 weeks, onabotulinumtoxinA 100 U provides greater relief of OAB symptoms compared with most other licensed doses of other pharmacotherapies in the network.
Keyphrases
  • gestational age
  • sleep quality
  • physical activity